COO logo

Cooper Companies (COO) Company Overview

Profile

Full Name:

The Cooper Companies, Inc.

Sector:

Healthcare

Industry:

Medical Instruments & Supplies

Country:

United States

IPO:

January 21, 1983

Indexes:

S&P 500

Website:

http://www.coopercos.com

Description:

Cooper Companies, Inc. operates as a medical equipment manufacturing company. It consists of two business units: CooperVision and CooperSurgical. The company develops, manufactures, and sells a range of contact lenses, including spherical lenses, as well as toric and multifocal lenses that correct nearsightedness and farsightedness, and address various complex vision defects such as astigmatism and presbyopia. It also provides a wide range of products and services for hospitals and surgical centers, obstetricians and gynecologists, as well as infertility clinics. Cooper Companies, Inc. was founded in 1980 and is based in San Ramon, California.

Key Details

Price

$85.00

Market Cap

$17.00 B(Large cap)

Last Dividend

$0.01

TTM Dividend Yield

-

Annual Revenue

$3.90 B(+8.41% YoY)

Annual EPS

$1.96(+32.43% YoY)

PE Ratio

41.26

Annual ROE

5.02%

Annual Debt To Equity

0.32

Beta

0.42

Events Calendar

Earnings

Next earnings date:

May 30, 2025

Recent quarterly earnings:

Mar 6, 2025

Recent annual earnings:

Dec 5, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Jul 26, 2023
Splits

Next split:

N/A

Recent split:

Feb 20, 2024

Analyst ratings

Recent major analysts updates

Mar 7, 25 Stifel
Buy
Mar 7, 25 Piper Sandler
Overweight
Mar 7, 25 Needham
Hold
Mar 7, 25 JP Morgan
Overweight
Mar 7, 25 Citigroup
Buy
Mar 7, 25 Baird
Outperform
Dec 6, 24 Wells Fargo
Overweight
Dec 6, 24 Needham
Hold
Dec 6, 24 Morgan Stanley
Equal-Weight
Dec 6, 24 Citigroup
Buy

Screeners with COO included

Growing Shares Outstanding
US stocks
High Piotroski score stocks
S&P 500 companies earnings calendar
Stocks below SMA 200
Most recommended stocks
Best performing stocks last 5 years
S&P 500 companies
Stocks below analysts price target
S&P 500 companies dividend calendar

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$85.00
COO price is $85.00

Price All-time High

$113.98
COO price is currently -25.43% below its historical high of $113.98

Price Analysts Target

$110.00
COO price is currently -22.73% lower than the consensus analysts' forecast

Price Most Recent Change

-1.75%
COO price was down -1.75% on Mar 7, 2025

Price YTD Change

-7.54%
COO price is down -7.54% since January 1st

Price 3-Year Change

-15.26%
COO price is down -15.26% over the past 3 years

Market cap

Market Cap

$17.00 B
COO market capitalization is $17.00 billion

Market Cap 3-Year Change

-14.07%
COO market capitalization is down -14.07% over the past 3 years

Market Cap All-time High

$22.48 B
COO market capitalization is currently -24.39% below its historical high of $22.48 billion

Market Cap Sector Rank

94.98%
COO market capitalization is higher than 94.98% of companies in Healthcare sector

Technical

Beta

0.42
COO beta is 0.42

200-day SMA

$97.10
COO price is currently -12.46% below its 200-day simple moving average

14-day RSI

32.86
COO 14-day relative strength index is 32.86

30-day Relative Volume

3.08
COO 30-day relative volume is 3.08

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.01
COO last dividend was $0.01 per share, with an ex-dividend date of July 26, 2023

Next Dividend

-
COO next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
COO annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
COO annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
COO annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
COO annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
COO annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
COO annual dividend yield is unknown

Other

Annual Payout Ratio

0.00%
COO annual payout ratio is 0.00%

Annual Dividends Paid

$0.00
COO annual dividends paid is $0.00

Annual FCF

$288.10 M
COO annual free cash flow is $288.10 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$3.90 B
COO annual revenue is $3.90 billion

Annual Revenue Analysts Estimate

$4.12 B
COO annual revenue is currently -5.46% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

+8.41%
COO annual revenue is up +8.41% year-on-year

Annual Revenue Sector Rank

90.03%
COO annual revenue is higher than 90.03% of companies in Healthcare sector

Profit

Annual Gross Profit

$2.60 B
COO annual gross profit is $2.60 billion

Annual Gross Margin

66.64%
COO annual gross profit margin is 66.64%

Annual Operating Profit

$705.70 M
COO annual operating income is $705.70 million

Annual Operating Margin

18.12%
COO annual operating profit margin is 18.12%

Annual Net Income

$392.30 M
COO annual net profit is $392.30 million

Annual Net Margin

10.07%
COO annual net profit margin is 10.07%

EPS

Annual EPS

$1.96
COO annual earnings per share is $1.96

Annual EPS Analysts Estimate

$3.99
COO annual earnings per share is currently -50.82% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

+32.43%
COO annual earnings per share is up +32.43% year-on-year

Annual EPS Sector Rank

92.03%
COO annual earnings per share is higher than 92.03% of companies in Healthcare sector

ROA & ROE

Annual ROA

3.27%
COO annual return on assets is 3.27%

Annual ROE

5.02%
COO annual return on equity is 5.02%

EBIT & EBITDA

Annual EBIT

$696.60 M
COO annual earnings before interest & taxes is $696.60 million

Annual EBITDA

$897.80 M
COO annual EBITDA is $897.80 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

41.26
COO price to earnings ratio is 41.26

PE Ratio Sector Rank

71.43%
COO price to earnings ratio is higher than 71.43% of companies in Healthcare sector

PB Ratio

PB Ratio

2.09
COO price to book ratio is 2.09

PB Ratio Sector Rank

60.54%
COO price to book ratio is higher than 60.54% of companies in Healthcare sector

PS Ratio

PS Ratio

4.33
COO price to sales ratio is 4.33

PS Ratio Sector Rank

58.02%
COO price to sales ratio is higher than 58.02% of companies in Healthcare sector

Enterprise value

Enterprise Value

$19.44 B
COO enterprise value is $19.44 billion

Enterprise Value Sector Rank

94.69%
COO enterprise value is higher than 94.69% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

17.74
COO EV/EBITDA is 17.74

EV/EBITDA Sector Rank

88.88%
COO EV/EBITDA is higher than 88.88% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.91
COO annual current ratio is 1.91

Annual Quick Ratio

1.12
COO annual quick ratio is 1.12

Leverage

Annual Debt To Equity

0.32
COO annual debt to equity ratio is 0.32

Annual Interest Coverage Ratio

6.09
COO annual interest coverage ratio is 6.09

Risk & Stability

Piotroski F-Score

8
COO piotroski f-score is 8

Altman Z-Score

3.83
COO altman z-score is 3.83

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$12.32 B
COO annual total assets is $12.32 billion

Annual Non Current Assets

$10.36 B
COO annual long term assets is $10.36 billion

Annual Current Assets

$1.95 B
COO annual total current assets is $1.95 billion

Annual Cash & Cash Equivalents

$107.60 M
COO annual cash & cash equivalents is $107.60 million

Equity

Annual Book Value

$8.08 B
COO annual book value is $8.08 billion

Annual Working Capital

$928.70 M
COO annual working capital is $928.70 million

Liabilities

Annual Total Liabilities

$4.23 B
COO annual total liabilities is $4.23 billion

Annual Total Long Term Liabilities

$3.21 B
COO annual total long term liabilities is $3.21 billion

Annual Current Liabilities

$1.02 B
COO annual total current liabilities is $1.02 billion

Annual Accounts Payable

$260.50 M
COO annual accounts payable is $260.50 million

Debt

Annual Total Debt

$2.58 B
COO annual total debt is $2.58 billion

Annual Total Debt 1-Year Change

+0.56%
COO annual total debt is up +0.56% year-on-year

Annual Long Term Debt

$2.55 B
COO annual long term debt is $2.55 billion

Annual Short Term Debt

$33.30 M
COO annual short term debt is $33.30 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$3.19 B
COO annual total expenses is $3.19 billion

Annual Operating Expenses

$1.89 B
COO annual total operating expenses is $1.89 billion

Annual Cost Of Goods Sold

$1.30 B
COO annual cost of goods sold is $1.30 billion

Annual SGA

$1.53 B
COO annual SGA is $1.53 billion

Annual D&A

$375.10 M
COO annual depreciation & amortization is $375.10 million

Annual Interest Expense

$114.30 M
COO annual interest expense is $114.30 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

$709.30 M
COO annual cash flow from operations is $709.30 million

Annual CFO 1-Year Change

+16.76%
COO annual cash flow from operations is up +16.76% year-on-year

Annual CFI

-$764.60 M
COO annual cash flow from investing activities is -$764.60 million

Annual CFI 1-Year Change

-70.29%
COO annual cash flow from investing activities is down -70.29% year-on-year

Annual CFF

$39.20 M
COO annual cash flow from financing activities is $39.20 million

Annual CFF 1-Year Change

+122.54%
COO annual cash flow from financing activities is up +122.54% year-on-year

Free CashFlow

Annual FCF

$288.10 M
COO annual free cash flow is $288.10 million

Annual FCF 1-Year Change

+34%
COO annual free cash flow is up +34% year-on-year

CAPEX

Annual CAPEX

$421.20 M
COO annual capital expenditures is $421.20 million

Annual CAPEX 1-Year Change

+7.31%
COO annual capital expenditures is up +7.31% year-on-year

Institutional Ownership

Similar stocks

WST logo
West Pharmaceutical Services (WST)
TEVA logo
Teva Pharmaceutical Industries Limited (TEVA)
MOH logo
Molina Healthcare (MOH)
PODD logo
Insulet (PODD)
BAX logo
Baxter International (BAX)
GMAB logo
Genmab A/S (GMAB)
ICLR logo
ICON Public Limited (ICLR)
NTRA logo
Natera (NTRA)
RPRX logo
Royalty Pharma (RPRX)

FAQ

  • What is the ticker symbol for Cooper Companies?
  • Does Cooper Companies pay dividends?
  • What sector is Cooper Companies in?
  • What industry is Cooper Companies in?
  • What country is Cooper Companies based in?
  • When did Cooper Companies go public?
  • Is Cooper Companies in the S&P 500?
  • Is Cooper Companies in the NASDAQ 100?
  • Is Cooper Companies in the Dow Jones?
  • When was Cooper Companies's last earnings report?
  • When does Cooper Companies report earnings?
  • Should I buy Cooper Companies stock now?

What is the ticker symbol for Cooper Companies?

The ticker symbol for Cooper Companies is NASDAQ:COO

Does Cooper Companies pay dividends?

No, Cooper Companies does not pay dividends

What sector is Cooper Companies in?

Cooper Companies is in the Healthcare sector

What industry is Cooper Companies in?

Cooper Companies is in the Medical Instruments & Supplies industry

What country is Cooper Companies based in?

Cooper Companies is headquartered in United States

When did Cooper Companies go public?

Cooper Companies's initial public offering (IPO) was on January 21, 1983

Is Cooper Companies in the S&P 500?

Yes, Cooper Companies is included in the S&P 500 index

Is Cooper Companies in the NASDAQ 100?

No, Cooper Companies is not included in the NASDAQ 100 index

Is Cooper Companies in the Dow Jones?

No, Cooper Companies is not included in the Dow Jones index

When was Cooper Companies's last earnings report?

Cooper Companies's most recent earnings report was on Mar 6, 2025

When does Cooper Companies report earnings?

The next expected earnings date for Cooper Companies is May 30, 2025

Should I buy Cooper Companies stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions